Biosimilars & Biologics Summit 2023

Description

• Emerging trends in developing biosimilars and biologic therapeutics
  Understand how the development of biosimilars improves access to therapeutic interventions and enhances healthcare affordability.

• The role of biosimilars design in the development of new drug modalities
  Achieve a deeper understanding of biosimilars as novel drug modalities beyond traditional small molecules, including RNA, complex peptides, proteins, glycoproteins, and antibodies.

• Exploring new technological advances for the enhanced production of biosimilars
  Learn how the latest research in upstream technology for enhanced production enabled biosimilar drugs as well-established therapeutic interventions.

• Latest research in bioavailability and bioequivalence assessment of biologic drugs
  Gain insights into statistical considerations in the design, bioavailability, safety, immunogenicity, and bioequivalence of biosimilars products.

• Regulatory and IP strategies for new-to-market biosimilar-based therapeutics
  Learn the key regulatory approaches and IP strategies for approval of biologics-based therapeutics to manage chronic disease in the emerging biosimilars market.

• Case studies, clinical trials, and pharmacometrics analysis for biosimilars development
  Hear from leading manufacturers and implement strategies that others in the industry use to ensure successful product development and challenges in bringing new therapies to market.